Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
PARIS, March 15, 2012 /PRNewswire/ -- Marken is pleased to share its year-end data which validates that it holds a market-leading position in the shipment of in-bound biological samples to the major central laboratories and to Pharma directly.
read more
Wednesday, March 14, 2012
Recipharm and ViroPharma today signed a commercial contract to initiate supply of Plenadren® for named patient use. In addition, ViroPharma are investing in capital equipment at the Recipharm manufacturing site - enabling large scale manufacturing ...
read more
MARLBOROUGH, MASSACHUSETTS, USA — March 12, 2012 — A new white paper detailing how a flexible bioprocessing platform meets the changing needs of biomanufacturing is now available for download from Xcellerex, Inc., at http://www.xcellerex.com/...
read more
“Frances Grote, Senior Director, Clinical Outsourcing at Millennium Pharmaceuticals is currently and has been one of our authors for years. She is a highly respected member of the pharmaceutical community and a frequent speaker and moderators at ...
read more
Tuesday, February 28, 2012
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the acquisition of PriceSpective LLC, a global leader in value strategy consulting. The acquisition ...
read more
Tuesday, February 28, 2012
Global pharmaceutical manufacturer and developer, Penn Pharma, has today [28 February 2012] announced a £14 million investment in its South Wales UK facility to strengthen its offering for international supply and further build on the company’s ...
read more
Tuesday, February 28, 2012
INC Research, LLC, a therapeutically focused clinical research organization (CRO) with a Trusted Process® for delivering reliable results, will discuss the evolution of clinical development outsourcing trends at the Partnerships(TM) in Clinical ...
read more
Tuesday, February 28, 2012
Almac, a leading provider of contract services to the global Pharmaceutical and Biotech industries, has addressed a surge in clinical outsourcing by acquiring two new pieces of encapsulation equipment at their North American headquarters in Souderton...
read more
Monday, February 27, 2012
EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, today announced it will be partnering with Charles River Laboratories International, Inc. of Wilmington, MA, to exclusively license EMD Millipore's TrueSpike™ technology. ...
read more
Wednesday, February 22, 2012
Global pharmaceutical manufacturer, Aesica, experienced significant growth in 2011, doubling both its turnover and its workforce and forming a number of long-term strategic partnerships with customers such as UCB and Noramco.
read more
Wednesday, February 22, 2012
NanoSonic Products, Inc., a wholly owned subsidiary of CTD Holdings, Inc., announced that the Company has signed a manufacturing agreement with Florida Biologix for the production of the sterile liquid form of its Trappsol Cyclo product, an orphan ...
read more
Tuesday, February 21, 2012
Xencor, Inc., a company using its proprietary Protein Design Automation® (PDA) platform technology to engineer next-generation antibodies, and Boehringer Ingelheim announced today a collaboration agreement for certain Xencor biosuperior monoclonal ...
read more
Tuesday, February 21, 2012
Jubilant Biosys Limited, Bangalore announced today that they have entered into drug discovery collaboration with Mnemosyne Pharmaceutical Inc, Providence, Rhode Island that will seek to identify preclinical candidates in the area of neuropsychiatric ...
read more
Tuesday, February 21, 2012
Service Eliminates Over-Packaging by Providing Deep Knowledge of a
Product’s Stability Barrier Needs Before It Is Packaged . . .
Leading to a “Just Right” Solution for Oral Dose Products in Six Weeks
read more
Friday, February 17, 2012
Catalent Pharma Solutions today announced that it has completed the acquisition of the Clinical Trial Supplies business of Aptuit LLC. The acquisition substantially expands Catalent’s Development & Clinical Services business, transforming it into the...
read more